Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Accelerated Approval ...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(109)
•••
Comment by gojotv!on Dec 05, 2022 2:53pm
293 Views
Post# 35151671

RE:RE:RE:RE:RE:RE:RE:Accelerated Approval ...

RE:RE:RE:RE:RE:RE:RE:Accelerated Approval ...$20/share?!... Oh, ye of little balls! 
Feel free to sell into the market at $20 if you wish, but this is a $500 stock.
(Especially with our tiny, little share float, that's bound to split and split again as interest grows...)
And I don't mind holding out from Big Pharma to get it there.
The whole reason BTD and AA exist is that generations have dreamed of a CURE for cancer, and didn't want bureaucratic holdups when it arrived. 
They wanted to ensure we could save every single possible life we could as soon as a safe, viable cure appeared.
And TLD-1433 is it!
We have the approach to cancer treatment that will revolutionize oncology!
That kind of desirability is worth trillions, not billions. And we could re-start Canada's Pharma industry, keeping our young minds here, and encouraging education and interest in healthcare for generations to come...!
GLTA!



riverrrow wrote: When TLT gets bought out for $20 both Justine and the CRA will be very happy.  GLTA.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities